Pontificia Universidad Catolica de Chile

16 marketed · 3 in Phase 3

Quick facts

Marketed products

Artificial Saliva
Cyclopentolate+tropicamide+phenylephrine · Ophthalmology
This combination of three anticholinergic and sympathomimetic agents dilates the pupil and paralyzes accommodation for ophthalmic examination.
H-Bupivacaine
Hepatitis B recombinant vaccine · Immunology
This recombinant vaccine stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.
Levobupivacaine 10 mL
Levobupivacaine 25 mL
Levobupivacaine with epinephrine · Anesthesia
Levobupivacaine blocks sodium channels in nerve cell membranes to produce local anesthesia, while epinephrine causes vasoconstriction to prolong the anesthetic effect and reduce systemic absorption.
Levobupivacaine without epinephrine · Anesthesia
Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.
Methadone Injectable Product
N-acetylcysteine 1000 mg
N-acetylcysteine 500 mg
Optimized bismuth quadruple therapy · Gastroenterology / Infectious Disease
Bismuth quadruple therapy combines bismuth subsalicylate with three antimicrobial agents to eradicate Helicobacter pylori infection through multiple mechanisms of action.
Post-operative · Pain management
This drug works by inhibiting the action of certain neurotransmitters in the brain.
Tamsulosin Hydrochloride 0.4 milligrams · Urology
Tamsulosin selectively blocks alpha-1A adrenergic receptors in the prostate and bladder neck, relaxing smooth muscle to improve urine flow.
Tretinoin 0.05% · Dermatology
Tretinoin is a retinoid that binds to retinoic acid receptors to regulate gene expression, promoting cell differentiation and reducing sebum production and comedone formation.
Water (Placebo)
Water acts as an inert placebo with no active pharmacological mechanism.

Phase 3 pipeline

Autologous Serum 20% · Ophthalmology
Autologous serum 20% is a topical ophthalmic preparation of the patient's own blood serum that provides growth factors and immunomodulatory components to promote corneal healing and reduce ocular surface inflammation.
Autologous Serum 50% · Ophthalmology
Autologous serum 50% is a patient's own blood serum diluted to 50% concentration, applied topically to provide growth factors and immunomodulatory components for tissue repair and healing.
Topical 2,5% lidocaine + 2,5% prilocaine gel · Pain management
Lidocaine and prilocaine work by blocking the action of sodium channels in nerve cells, preventing the transmission of pain signals.

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Pontificia Universidad Catolica de Chile

What are Pontificia Universidad Catolica de Chile's marketed drugs?

Top marketed products include Artificial Saliva, Cyclopentolate+tropicamide+phenylephrine, H-Bupivacaine, Hepatitis B recombinant vaccine, Levobupivacaine 10 mL, Levobupivacaine 25 mL.

What is Pontificia Universidad Catolica de Chile's pipeline?

Pontificia Universidad Catolica de Chile has 3 drugs in Phase 3, 7 in Phase 2, 6 in Phase 1. Late-stage candidates include Autologous Serum 20%, Autologous Serum 50%, Topical 2,5% lidocaine + 2,5% prilocaine gel.

Artificial Saliva
Cyclopentolate+tropicamide+phenylephrine · Ophthalmology
H-Bupivacaine
Hepatitis B recombinant vaccine · Immunology
Levobupivacaine 10 mL
Sector hub: All tracked pharma companies